Introduction
Reglide Plus is a prescription medication that contains two active ingredients: Repaglinide and Metformin. It is available in tablet form and is used primarily for the management of type 2 diabetes.
Uses
Reglide Plus is prescribed to individuals with type 2 diabetes to help control their blood sugar levels. It is typically used in conjunction with a healthy diet and regular exercise. This medication works by increasing insulin production in the pancreas and reducing the amount of glucose produced by the liver.
Dosage and Administration
The dosage of Reglide Plus will vary depending on individual factors such as age, weight, and the severity of the condition. Follow your healthcare provider’s instructions regarding the dosage and administration of this medication. Typically, the initial dose is one tablet taken with meals, usually three times a day. Your healthcare provider may adjust the dose as necessary to achieve optimal blood sugar control.
Mechanism of Action
Reglide Plus contains two active ingredients, Repaglinide and Metformin, which work together to help manage blood sugar levels in individuals with type 2 diabetes. Repaglinide stimulates the pancreas to produce insulin, while Metformin reduces the production of glucose by the liver and improves the body’s sensitivity to insulin.
Side Effects
Common side effects may include nausea, diarrhea, stomach upset, headache, and dizziness. These side effects are usually mild and temporary. However, if you experience any serious side effects such as signs of low blood sugar (e.g., sweating, shaking, confusion) or allergic reactions (e.g., rash, itching, swelling), seek medical attention immediately.
Drug Interactions
Reglide Plus may interact with certain medications, including other antidiabetic drugs, certain antibiotics, and medications that affect liver function. Inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions. Your healthcare provider will be able to determine if any adjustments to your medication regimen are necessary.
Precautions
Before taking Reglide Plus, inform your healthcare provider about any pre-existing medical conditions, including liver or kidney problems, heart conditions, and allergies. This medication may not be suitable for individuals with certain medical conditions or those who are pregnant or breastfeeding. Follow your healthcare provider’s advice and precautions.
Storage
Reglide Plus should be stored at room temperature, away from moisture and heat. Keep this medication out of reach of children and pets. Do not use Reglide Plus after the expiration date printed on the packaging.
Patient Tips
- Take Reglide Plus with meals as directed by your healthcare provider.
- Follow a healthy diet and exercise regularly to maximize the effectiveness of this medication.
- Monitor your blood sugar levels regularly and keep track of any changes or patterns.
- Inform your healthcare provider about any new symptoms or side effects you experience.
- Attend regular check-ups with your healthcare provider to monitor your condition and adjust your medication regimen if necessary.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Metformin: a medicine to treat type 2 diabetes (NHS UK) [Accessed 10 Jun. 2024] (online) Available at:
- Competact 15 mg/850 mg film-coated tablets (Health Professionals SmPC) Available at:
- Metformin (Drugs.com) [Accessed 6 Jun. 2024] (online) Available at:
- metformin (RX) [Accessed 21 Jun. 2024] (online) Available at:
- Metformin (MedlinePlus) [Accessed 2 Jun. 2024] (online) Available at:
- LaMoia TE, Shulman GI. Cellular and Molecular Mechanisms of Metformin Action. Endocr Rev. 2021 Jan 28;42(1):77-96. doi: 10.1210/endrev/bnaa023. [Accessed 21 Jun. 2024] Available at:
Reviews
There are no reviews yet.